Ponalrestat
Ponalrestat, an aldose reductase inhibitor, activates lipoprotein lipase (LPL) activity in the adipose tissue and alleviates the cachectic symptoms induced by B16 melanoma in mice.
Product Specifications
CAS Number
72702-95-5
Product Name Alternative
ICI 128436 | MK-538 | Ponalrestat
Purity
>98% (HPLC)
Solubility
DMSO: 10 mM
Smiles
O=C (O) CC1=NN (CC2=CC=C (Br) C=C2F) C (C3=C1C=CC=C3) =O
Molecular Formula
C17H12BrFN2O3
Molecular Weight
391.19
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
2- (3- (4-bromo-2-fluorobenzyl) -4-oxo-3,4-dihydrophthalazin-1-yl) acetic acid
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4107807 1.0 µg DNA
Trim11 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
Sign In for Pricing
View Details 
T2234161 5 Slides
Paraffin Tissue Section - Human Adult Normal: Lymph Node
Sign In for Pricing
View Details 
MBS4165664-01 0.1 mg
Purified Anti-Human CD274 PD-L1 (B7-H1) (29E.2A3)
Sign In for Pricing
View Details MBS4165664-02 5x 0.1 mg
Purified Anti-Human CD274 PD-L1 (B7-H1) (29E.2A3)
Sign In for Pricing
View Details